Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Open-market sale Chief Financial Officer sold 18,091 shares at $1.47 ($26,547)
  2. 4 Open-market sale Chief Medical Officer sold 16,306 shares at $1.47 ($23,927)
  3. 4 Open-market sale Chief Financial Officer sold 16,489 shares at $2.52 ($41,542)
  4. 4 Open-market sale Chief Executive Officer sold 52,172 shares at $2.52 ($131,442)
  5. 4 Open-market sale President and Head of R&D sold 26,500 shares at $2.52 ($66,764)
  6. 4 Open-market sale Chief Medical Officer sold 14,892 shares at $2.52 ($37,519)
  7. 4 Grant or award Director acquired 15,833 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 216,400 shares (grant or award)
  9. 4 Grant or award President and Head of R&D acquired 300,000 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 610,500 shares (grant or award)
  11. 4 Grant or award Chief Medical Officer acquired 184,380 shares (grant or award)
  12. 4 Open-market sale Chief Financial Officer sold 7,297 shares at $4.88 ($35,620)
  13. 4 Open-market sale Chief Executive Officer sold 26,499 shares at $4.88 ($129,387)
  14. 4 Open-market sale President and Head of R&D sold 13,926 shares at $4.88 ($67,981)
  15. 4 Open-market sale Chief Medical Officer sold 8,478 shares at $4.88 ($41,385)
  16. 4 Open-market sale Director sold 44,250 shares at $5.16 ($228,388)
  17. 4 Planned sale Director sold 10,500 shares at $5.06 ($53,179)
  18. 4 Planned sale Director sold 5,000 shares at $5.06 ($25,309)
  19. 4 Grant or award Director acquired 35,000 shares (grant or award)
  20. 4 Grant or award Director acquired 35,000 shares (grant or award)

Page 4 of 16 · 301 filings